CD274 and breast cancer: To the best of our knowledge, there is only one study of 16 patients with HR+/HER2− metastatic BC [29], reporting the detection of PD-L1+ CTCs in the majority of CTC-positive patients as compared to only one third of CTC-positive patients described in our study.